LON:AGL

ANGLE - AGL Share Forecast, Price & News

GBX 29

-0.50 (-1.69%)

(As of 02/1/2023 10:40 AM ET)

Add

Compare

Today's Range: 27.05
▼
29.75
50-Day Range: 24
▼
56
52-Week Range: 22.20
▼
163.75

Volume: 2.08 million shs
Average Volume: 5.97 million shs
Market Capitalization: £75.57 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: GBX 120

About ANGLE (LON:AGL) Stock

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

AGL Stock News Headlines

January 13, 2023 | foxnews.com

WWE legend Kurt Angle credits daughter with saving him from drowning in scary jet ski incident

January 5, 2023 | proactiveinvestors.com

ANGLE says it sees significant expansion opportunities for the streamlined business as it moves into 2023

February 1, 2023 | Investor Place Media (Ad)

Cash Holders STILL Aren't Taking Steps to Prepare

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

January 5, 2023 | finance.yahoo.com

Angle plc Announces Appointment of Non-Executive Director

December 12, 2022 | finance.yahoo.com

Angle PLC Announces Two Parsortix Posters Presented at SABCS

November 2, 2022 | proactiveinvestors.com

ANGLE says Parsortix system used for multiple tests in breast cancer study

November 2, 2022 | finance.yahoo.com

Angle PLC Announces Multiple Downstream Analysis Techniques for CTCs

October 12, 2022 | proactiveinvestors.com

ANGLE inks first regional distribution deal for breakthrough liquid biopsy system

February 1, 2023 | Investor Place Media (Ad)

Cash Holders STILL Aren't Taking Steps to Prepare

October 12, 2022 | finance.yahoo.com

Angle PLC Announces First Regional Distribution Agreement

September 28, 2022 | msn.com

How to Manage Deadstick Approaches

September 28, 2022 | finance.yahoo.com

Angle PLC announces Study using Parsortix in head and neck cancer

September 12, 2022 | finanznachrichten.de

ANGLE plc: Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass

September 12, 2022 | finance.yahoo.com

Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass

September 2, 2022 | morningstar.com

Angle PLC Announces Notice of Interim Results and Webcast | Morningstar

August 13, 2022 | finance.yahoo.com

ANGLE plc (AGL.L)

June 29, 2022 | finance.yahoo.com

Angle PLC Announces Result of 2022 Annual General Meeting

June 27, 2022 | finanznachrichten.de

ANGLE plc: Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep

June 22, 2022 | proactiveinvestors.com

ANGLE says second pharma services contract shows confidence in 'totally new approach'

June 22, 2022 | proactiveinvestors.com

ANGLE lands repeat business with pharma client - Proactive Investors USA

June 22, 2022 | finance.yahoo.com

Angle PLC Announces Secured Contract From Pharma Services Customer

June 17, 2022 | finanznachrichten.de

ANGLE plc: Angle PLC Announces Predicting Immunotherapy Response in SCLC

June 16, 2022 | proactiveinvestors.com

ANGLE: Researchers highlight potential of company's liquid biopsy in lung cancer

June 16, 2022 | apnews.com

Angle PLC Announces Predicting Immunotherapy Response in SCLC

June 15, 2022 | finance.yahoo.com

Angle PLC Announces Potential Role of Invasive Cellular Protrusions

June 14, 2022 | finanznachrichten.de

ANGLE plc: Angle PLC Announces Potential Role of Invasive Cellular Protrusions

May 30, 2022 | ca.proactiveinvestors.com

ANGLE inks prostate cancer study agreement with US healthcare group and its affiliate

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

AGL Company Calendar

Last Earnings: 1/30/2020
Today: 2/01/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Laboratories & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:AGL
CUSIP: N/A
CIK: N/A
Web: www.angleplc.com
Phone: +44-1483-685830
Fax: N/A
Employees: 102
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: GBX 120
High Stock Price Forecast: GBX 120
Low Stock Price Forecast: GBX 120
Forecasted Upside/Downside: +313.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 16.43
Current Ratio: 6.55
Quick Ratio: 6.18

Sales & Book Value

Annual Sales: £1.14 million
Price / Sales: 66.52
Cash Flow: GBX 5 per share
Price / Cash Flow: 5.80
Book Value: GBX 13.60 per share
Price / Book: 2.13

Miscellaneous

Outstanding Shares: 260,581,000
Free Float: N/A
Market Cap: £75.57 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Andrew David William Newland (Age 61)
Founder, CEO & Exec. Director
Comp: $446k

Mr. Ian Francis Griffiths (Age 58)
CFO, Fin. Director, Company Sec. & Exec. Director
Comp: $284k

Mr. Martin Cooke (Age 54)
Director of Operations & Regulatory Affairs

Mr. Andrew John Holder (Age 55)
Head of Investor Relations

Mr. Paul Smith
Chief Commercial Officer

Dr. Madeline Repollet
Head of Clinical Laboratories

Ms. Anne-Sophie Pailhes-Jimenez
Head of R&D - ANGLE Europe Ltd.

Mr. Michael O'Brien
Bus. Devel. Director

Key Competitors

View All Competitors

Insiders & Institutions

Andrew D Newland
Bought 125,000 shares on 7/19/2022
Total: £10 M ($80.00/share)

View All Insider Transactions

AGL Stock - Frequently Asked Questions

Should I buy or sell ANGLE stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.
What is ANGLE's stock price forecast for 2023?: 1 Wall Street analysts have issued 1-year target prices for ANGLE's stock. Their AGL share price forecasts range from GBX 120 to GBX 120. On average, they predict the company's share price to reach GBX 120 in the next year. This suggests a possible upside of 306.8% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.
How have AGL shares performed in 2023?: ANGLE's stock was trading at GBX 50.50 at the start of the year. Since then, AGL stock has decreased by 41.6% and is now trading at GBX 29.50.
View the best growth stocks for 2023 here.
How were ANGLE's earnings last quarter?: ANGLE plc (LON:AGL) announced its quarterly earnings data on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter.

What other stocks do shareholders of ANGLE own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).
What is ANGLE's stock symbol?: ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."
How do I buy shares of ANGLE?: Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is ANGLE's stock price today?: One share of AGL stock can currently be purchased for approximately GBX 29.50.
How much money does ANGLE make?: ANGLE (LON:AGL) has a market capitalization of £76.87 million and generates £1.14 million in revenue each year.
How many employees does ANGLE have?: The company employs 102 workers across the globe.
How can I contact ANGLE?: ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.angleplc.com. The company can be reached via phone at +44-1483-685830.

This page (LON:AGL) was last updated on 2/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial